BioSpace News Archive

Kit CheckTM, the leader in automated medication management solutions for hospitals, today announced that its Bluesight for Controlled Substances diversion prevention and controlled substance management solution has closed over one million cases*.

IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune modulating anti-cancer therapies, based on its proprietary T-win® technology, presented preclinical data on the therapeutic potential of an immunomodulatory CCL22-based vaccine

Young Living looks back at two-and-a-half decades of major milestones and skyrocketing success

The American College of Rheumatology has released new drug pricing and step therapy position statements that they hope legislators will consider as they continue to explore policy and regulatory options to make drugs more affordable and accessible.

Independent physicians and their patients will benefit from single, merged view of health information

Twenty-five years after California adopted stringent requirements to keep hospitals operational after an earthquake, a new report by the RAND Corporation suggests state lawmakers should consider policy alternatives that take into account the massive financial costs and reflect the way health care is now delivered.

Replays of the webcast will be available on the LivaNova website within 24 hours after the live presentation for 90 days after the event.

ImpediMed will become Business Associate-compliant and launch third-generation software for its award-winning SOZO Digital Health Platform.

Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company developing a broad pipeline of innovative treatments for cancer, today announces the appointment of Ian Smith, M.D., as Chief Medical Officer

Pharmacokinetic (PK)/pharmacodynamic (PD) study for PXL770 is expected to initiate 2Q 2019 with results anticipated 2H 2019